A prognostic marker for cardiac cancer and its application
A cardia adenocarcinoma and prognosis technology, which is applied in the field of cardiac cancer prognosis prediction markers, can solve the problems of few molecular markers, unaccepted clinical application, poor prognosis of cardia cancer, etc., and achieves simple operation and convenient prognosis prediction. , easy to use effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Example 1: A method for detecting the expression level of ERICH3 protein, a prognostic marker for cardiac cancer
[0037] The expression level of ERICH3 protein was detected by immunohistochemical method, and the specific steps were as follows:
[0038]1. Fabrication of tissue chip: Cardiac cancer and adjacent normal tissues were fixed with 10% neutral formalin fixative for 48 hours, washed with tap water, and dehydrated with gradient alcohol (70% ethanol for 2 hours, 80% ethanol for 2 hours, 90% ethanol for 2 hours, Ethanol for 3 hours, 95% ethanol for 3 hours, absolute ethanol I for 2 hours, absolute ethanol II for 1 hour), xylene transparent (xylene I for 2 hours, xylene I for 2 hours), 54~58°C paraffin wax dipping (wax dipping I ( 54~56℃) for 30 minutes, soak in wax II (56~58℃) for 1 hour, soak in wax III (56~58℃) for 1 hour), embed into wax blocks, cut into 5um thick slices with a microtome and paste on Place the slides in a dry oven at 65°C overnight, and then pe...
Embodiment 2
[0045] Example 2: Application of ERICH3 protein in prognosis prediction of cardiac cancer
[0046] 1. Retrospective study: Immunohistochemical detection of ERICH3 protein expression in cardia cancer tumor tissue and adjacent normal tissue
[0047] Tissue microarrays were prepared from 150 cardiac cancer tumor tissue samples and their paired adjacent normal tissues, in which 2 spots were taken for the tumor tissue of each patient, and 2 spots were taken for the adjacent normal tissues. The expression level of ERICH3 protein was detected by the immunohistochemical method described in Example 1, and scored and analyzed.
[0048] (1) sample
[0049] All patients were diagnosed after pathological diagnosis and clinical diagnosis; the patient's tumor tissue samples and paracancerous tissue samples were surgical resection specimens; after the samples were collected, they were routinely made into paraffin specimens, sliced, and after HE staining, the area rich in cancer tissue was se...
Embodiment 3
[0095] Example 3: Preparation of a kit for prognostic prediction of cardiac cancer
[0096] A kit for predicting the prognosis of cardia cancer. The kit contains an antibody capable of specifically binding to the ERICH3 protein. The antibody is purchased from Thermo Fisher Scientific, and the article number is PA5-55933. The kit uses immunohistochemical method to quantitatively detect the ERICH3 protein in the surgically resected tissue samples or endoscopic biopsy tissue samples of cardiac cancer, and determines the expression level of ERICH3 protein in the surgically resected tissue samples or endoscopic biopsy tissue samples of cardiac cancer. And according to the expression level of ERICH3 protein to distinguish the length of survival of cardiac cancer patients. Further, the kit also contains a detection buffer and a chromogenic reagent.
[0097] The kit judges the expression level of the ERICH3 protein according to the immunohistochemical staining score of the detected t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com